Modified Ac-TMP-2 Protein Truncation for Broad Anti-Inflammatory Use
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for treating inflammation are limited in their broad-based efficacy, particularly for conditions such as asthma and inflammatory bowel disease.
Innovation Solution
Utilization of modified hookworm proteins, specifically Ancylostoma caninum-derived Ac-TMP-2 proteins with altered N- and C-terminal amino acids, to reduce, alleviate, or prevent inflammation and associated diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If modified hookworm proteins are used to treat inflammation, then anti-inflammatory efficacy is improved, but treatment complexity increases
Solution Approach 1:
The invention extracts and utilizes specific anti-inflammatory proteins (Ac-TMP-2) from hookworms, isolating the beneficial therapeutic component from the whole organism. This allows the therapeutic effect to be achieved through purified protein administration rather than whole-worm therapy, improving efficacy while reducing treatment complexity through targeted molecular intervention
Solution Approach 2:
The invention modifies the Ac-TMP-2 protein by altering its N- and C-terminal amino acid sequences to optimize its anti-inflammatory activity. These parameter changes in the protein structure enhance therapeutic efficacy while maintaining the fundamental mechanism of action, providing improved treatment without requiring complex multi-component therapies
2Adaptability or versatility
If existing inflammation treatment methods are used, then treatment simplicity is maintained, but broad-based efficacy is insufficient
Solution Approach 1:
The modified Ac-TMP-2 protein demonstrates broad-based efficacy across multiple inflammatory conditions including asthma and inflammatory bowel disease. The single protein agent addresses diverse inflammatory pathways and disease manifestations, providing universal therapeutic coverage that exceeds the specificity of conventional treatments while maintaining a unified treatment approach
Solution Approach 2:
The invention employs the modified hookworm protein as an intermediary agent that mediates anti-inflammatory effects through specific molecular interactions with the immune system. This intermediary approach allows the treatment to bridge multiple disease states and inflammatory responses through a common mechanistic pathway, achieving broad efficacy without requiring disease-specific protocols
Data Source
AI summary
A modified Ac-TMP-2 protein lacks one or a plurality of acidic C-terminal amino acids normally present in a full-length or wild-type Ac-TMP-2 protein and may also lack one or a plurality of N-terminal amino acids while retaining the amino acid sequence C—S—C at or near the N-terminus. The modified Ac-TMP-2 protein may be useful in method and composition for reducing or alleviating inflammation in a subject. Inflammation may be associated with a disease is a disease of the digestive tract such as chronic gastritis or an inflammatory bowel disease such as Crohn's disease or ulcerative colitis, or a disease of the respiratory system, such as asthma, emphysema, chronic bronchitis, and chronic obstructive pulmonary disease.